CTS communications distributed on July 6th and July 20th. In working with Grifols on the availability of ZIKV test reagents, CTS projects that you should be prepared to convert from a ZIKV clinical trial test to a licensed test as early as October 29, 2018. The communication includes a quick survey link and instructions to register for the upcoming webinar.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...